Back
Johnson & Johnson 10K Form
Buy
60
JNJ
Johnson & Johnson
Last Price:
$202.60
Seasonality Move:
1.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2025-11-15 | 10K | JNJ/Johnson & Johnson Annual |
| 2025-10-15 | 10K | JNJ/Johnson & Johnson Annual |
| 2025-09-15 | 10K | JNJ/Johnson & Johnson Annual |
| 2025-08-15 | 10K | JNJ/Johnson & Johnson Annual |
| 2025-07-15 | 10K | JNJ/Johnson & Johnson Annual |
| 2025-06-15 | 10K | JNJ/Johnson & Johnson Annual |
Receive JNJ News And Ratings
See the #1 stock for the next 7 days that we like better than JNJ
JNJ Financial Statistics
Sales & Book Value
| Annual Sales: | $88.8B |
|---|---|
| Cash Flow: | $8B |
| Price / Cash Flow: | 24.33 |
| Annual Sales: | $32.95 |
| Price / Book: | 6.24 |
Profitability
| EPS (TTM): | 10.36180 |
|---|---|
| Net Income (TTM): | $25.1B |
| Gross Margin: | $61B |
| Return on Equity: | 33.27% |
| Return on Assets: | 13.39% |
Johnson & Johnson Earnings Forecast
Key Johnson & Johnson Financial Ratios
-
The Gross Profit Margin over the past 45 years for JNJ is 68.63%.
-
The Selling, General & Administrative Expenses for JNJ have been equal to 25.75% of Gross Profit Margin.
-
The Research & Development expenses have been 19.44% of Revenue.
-
The Interest Expense is 8.18% of Operating Income.
-
The Net Earning history of JNJ is 15.84% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 29 years.
Johnson & Johnson Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | JNJ |
| CUSIP: | 478160 |
| Website: | jnj.com |
Debt
| Debt-to-Equity Ratio: | 0.58 |
|---|---|
| Current Ratio: | 1.07 |
| Quick Ratio: | 0.71 |
Price-to-Earnings
| Trailing P/E Ratio: | 35.46 |
|---|---|
| Forward P/E Ratio: | 17.83 |
JNJ Technical Analysis vs Fundamental Analysis
Buy
60
Johnson & Johnson (JNJ)
is a Buy
Is Johnson & Johnson a Buy or a Sell?
-
Johnson & Johnson stock is rated a BuyThe current Johnson & Johnson [JNJ] share price is $205.33. The Score for JNJ is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.